Page last updated: 2024-09-02

liquiritigenin and Angiogenesis, Pathologic

liquiritigenin has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, YQ; Liu, CW; Luo, K; Wang, Y; Xie, SR1
Cai, Y; Liu, Y; Luo, K; Wang, Y; Xie, S1

Other Studies

2 other study(ies) available for liquiritigenin and Angiogenesis, Pathologic

ArticleYear
Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
    Phytotherapy research : PTR, 2012, Volume: 26, Issue:8

    Topics: Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Flavanones; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Biosynthesis; Protein Stability; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Serum; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptional Activation; Vascular Endothelial Growth Factor A

2012
Liquiritigenin inhibits tumor growth and vascularization in a mouse model of HeLa cells.
    Molecules (Basel, Switzerland), 2012, Jun-12, Volume: 17, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Flavanones; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012